Last reviewed · How we verify

irradiated RBC — Competitive Intelligence Brief

irradiated RBC (irradiated RBC) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cellular immunotherapy / Cancer vaccine. Area: Oncology / Immunology.

phase 3 Cellular immunotherapy / Cancer vaccine Oncology / Immunology Biologic Live · refreshed every 30 min

Target snapshot

irradiated RBC (irradiated RBC) — Federal Research Institute of Pediatric Hematology, Oncology and Immunology. Irradiated red blood cells act as an immunogenic cellular vaccine to stimulate anti-tumor immune responses.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
irradiated RBC TARGET irradiated RBC Federal Research Institute of Pediatric Hematology, Oncology and Immunology phase 3 Cellular immunotherapy / Cancer vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cellular immunotherapy / Cancer vaccine class)

  1. Federal Research Institute of Pediatric Hematology, Oncology and Immunology · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). irradiated RBC — Competitive Intelligence Brief. https://druglandscape.com/ci/irradiated-rbc. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: